{
    "clinical_study": {
        "@rank": "111135", 
        "arm_group": {
            "arm_group_label": "Hookah smoking", 
            "arm_group_type": "Experimental", 
            "description": "Healthy habitual Hookah smokers will undergo microneurography, myocardial contrast echocardiogram or venous occlusion plethysmography before and after Hookah smoking."
        }, 
        "brief_summary": {
            "textblock": "This is a pilot study on acute effects of Hookah smoking on the sympathetic neural control\n      of the human cardiovascular system. Hookah smoking is known to transiently increase blood\n      pressure and heart rate while decreasing heart rate variability suggesting - but not proving\n      - sympathetic mediation. Here the investigators will directly measure the acute effects of\n      Hookah smoking on sympathetic nerve activity with microneurography (intraneural\n      microelectrodes) and quantify associated regional changes in vasomotor tone."
        }, 
        "brief_title": "Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hookah Smoking", 
        "condition_browse": {
            "mesh_term": "Smoking"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 to 39 years of age\n\n          -  Habitual Hookah smoker defined as having smoked Hookah >=12 times in the  past 12\n             months\n\n          -  Have not smoked cigarettes within the past 12 months\n\n        Exclusion Criteria:\n\n          -  Exhaled carbon monoxide level greater than 10 ppm* as evidence of current or recent\n             cigarette (excluded if smoked cigarette within 12 months) or Hookah smoking (excluded\n             if smoked Hookah within past 72 hours)\n\n          -  History of cardiopulmonary disease\n\n          -  Use of any prescription medication with exception of oral contraceptive pills\n\n          -  History of psychiatric illness\n\n          -  History of neurologic disease\n\n          -  BMI \u2265 35\n\n          -  Evidence of any of the above by physical examination, ECG or echocardiogram\n\n          -  Smoked cigarette in the past 12 months\n\n          -  History of illicit drug use\n\n          -  Pregnant\n\n          -  Any other condition(s) deemed by the physician investigators that put subjects at\n             risk for participating in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "39 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02147665", 
            "org_study_id": "Pro00031150"
        }, 
        "intervention": {
            "arm_group_label": "Hookah smoking", 
            "description": "Subjects will smoke waterpipe in a controlled research environment.", 
            "intervention_name": "Hookah smoking", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hookah", 
            "waterpipe", 
            "smoking", 
            "sympathetic"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "location": {
            "contact": {
                "email": "havah.jaffe@cshs.org", 
                "last_name": "Havah Jaffe", 
                "phone": "310-248-7641"
            }, 
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90048"
                }, 
                "name": "Cedars-Sinai Medical Center"
            }, 
            "investigator": {
                "last_name": "Ronald G Victor, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin", 
        "other_outcome": {
            "description": "Lower leg blood flow will be measured with standard venous occlusion plethysmography.", 
            "measure": "Venous Occlusion Plethysmography", 
            "safety_issue": "No", 
            "time_frame": "At the initial study visit"
        }, 
        "overall_contact": {
            "email": "havah.jaffe@cshs.org", 
            "last_name": "Havah Jaffe", 
            "phone": "3102487641"
        }, 
        "overall_official": {
            "affiliation": "Cedars-Sinai Medical Center", 
            "last_name": "Ronald G Victor, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Multi-unit recordings of sympathetic nerve activity will be obtained with single-use sterile tungsten microelectrodes inserted selectively into muscle or skin nerve fascicles of the peritoneal nerve.", 
            "measure": "Sympathetic nerve activity", 
            "safety_issue": "No", 
            "time_frame": "At the initial study visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02147665"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cedars-Sinai Medical Center", 
            "investigator_full_name": "Ron Victor", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Myocardial contrast echocardiography will be used to measure regional myocardial perfusion (i.e. capillary blood volume) and coronary flow reserve.", 
            "measure": "Myocardial contrast echocardiography", 
            "safety_issue": "No", 
            "time_frame": "At the initial study visit"
        }, 
        "source": "Cedars-Sinai Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cedars-Sinai Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}